High materiality9/10
First Tracks Biotherapeutics price target raised to $70 from $62 at Wells Fargo
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wells Fargo raises TRAX target to $70 from $62; current price $34.05.
- Target raised to $70; current price $34.05.
Key facts
- 01
Target: $70
- 02
Posted price: $34.05
- 03
Analyst firm: Wells Fargo
- 04
Analyst: Derek Archila
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.